Posts by: Janet Stewart, MSc

Janet Stewart, MSc

Janet Stewart is a life sciences writer and editor, who completed both PhD course work and oral examinations in the Department of Microbiology and Immunology at McGill University, and holds an M.Sc. in Virology and Immunology.

October 16, 2018October 16, 2018

Study Identifies Predictors of Poor Outcome in Patients with SSc at Risk for Pulmonary Hypertension

News

A study identified predictors for hospitalization due to lung and heart problems and mortality in systemic sclerosis (SSc) patients at risk for pulmonary hypertension (PH). Being a man, having a reduced ... Read more

August 23, 2018August 23, 2018

Scleroderma Patients with Renal Disease Live Longer After Kidney Transplant, Study Finds

News

A European Union study found that patients with end-stage renal disease (ESRD) due to scleroderma who undergo a kidney transplant have a greater chance of surviving for five years or more, ... Read more

July 3, 2018July 3, 2018

Variability of Pulmonary Hypertension in SSc Patients Demands Tailored Treatments, Study Argues

News

Considerable differences in features of pulmonary hypertension among people with systemic sclerosis (SSc) markedly affect their survival chances, and treatment approaches given should be tailored accordingly, according to an analysis ... Read more

May 15, 2018May 15, 2018

Methotrexate Superior to Phototherapy in Childhood Localized Scleroderma, Study Finds

News

A methotrexate (MTX) treatment protocol that includes the administration of glucocorticoids is superior to phototherapy in treating childhood localized scleroderma, a study found. Nonetheless, researchers suggest MTX should be used ... Read more

December 12, 2017December 12, 2017

Actemra Seen to Improve Skin Symptoms, Treat Lung Disease in SSc Patients in Extended Trial

News

An extension of a Phase 2/3 study testing Actemra (tocilizumab) in patients with systemic sclerosis (SSc) found that skin involvement improved with 48 additional weeks of treatment. A Phase 3 trial ... Read more

September 5, 2017September 5, 2017

Focus Group Study Looks at How Patients Often Cope with Scleroderma

News

An analysis of focus group discussions between patients with systemic sclerosis (SSc), or scleroderma, found that participants coped with their disease in three general ways: by concentrating on solutions to ... Read more

August 17, 2017January 4, 2018

New Pre-Scleroderma Classification May Help Manage Disease, Predict Outcomes

News

A recent study showed that the classification of patients with pre-scleroderma into “very early systemic sclerosis” (SSc or scleroderma) and “early SSc” groups — based on the existence of subclinical organ involvement ... Read more

May 30, 2017May 30, 2017

High Levels of Thioredoxin-1 Restore Normal Skin Tissue in Mice with Systemic Sclerosis, Study Shows

News

Injecting bone marrow cells designed to produce high levels of thioredoxin 1 (Trx-1) restored skin tissue in mice with systemic sclerosis (SSc), according to Chinese researchers. Their study, “Bone Marrow-Derived Mesenchymal ... Read more

March 23, 2017March 23, 2017

White Blood Cells Known as CD16+ Monocytes Appear Linked to Fibrosis in SSc Patients

News

The number of white blood cells known as CD16+ monocytes is notably greater in the blood of systemic sclerosis (SSc) patients when skin or lung fibrosis is present, researchers said, recommending that ... Read more

March 14, 2017March 14, 2017

Systemic Sclerosis Patients in Australia Not Always Screened for PAH Despite Guidelines

News

Physician adherence to guidelines for screening for pulmonary arterial hypertension (PAH) in patients with systemic sclerosis (SSc) was found to be poor in Australia, according to a multi-center research study ... Read more